The value of fixed reimbursement insurance against cancer related losses: simulations to investigate state dependent utility
by Christopher J. Longo; Michel Grignon
Global Business and Economics Review (GBER), Vol. 14, No. 4, 2012

Abstract: Insurance literature discusses the theoretical role of state dependent utility (SDU), but empirical evidence is scant. Critical illness insurance (CII) is a fixed-reimbursement scheme where individuals buy a policy in case of an illness, and which provides an opportunity to empirically assess SDU motives. We investigate the potential role of SDU in CII purchasing behaviour, and propose consumers purchase CII depending on three competing factors: illness expenditures not fully covered through public and private mechanisms, forgone income due to absence or job loss, and finally desire for income transfer when sick. We run simulations using Canadian datasets of individual earnings, industry-based information on purchased CII policy reimbursement amounts, and original data on cancer expenditures. We use the residual between what is purchased through CII (face amount) and what should be purchased to cover personal health expenditures and forgone income as our estimate of an SDU-based motivation for buying CII.

Online publication date: Tue, 29-Jul-2014

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the Global Business and Economics Review (GBER):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com